Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.50
Bid: 40.00
Ask: 41.00
Change: 0.00 (0.00%)
Spread: 1.00 (2.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 40.50
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

Tue, 11th Aug 2020 12:36

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Codemasters Group Holdings PLC - Warwickshire-based video game developer - Revenue and adjusted earnings before interest, tax, depreciation and amortisation will be "significantly" ahead of market expectations in year to March 31, 2021. Codemasters notes strong performance from F1 2020 game, latest instalment of Formula One games.

----------

Parity Group PLC - London-based recruitment and professional services firm - Signs partnership agreement with CyberGym to offer cyber-warfare preparedness training. The due win a place on the NI.CO Cyber Security Training Services Framework to provide consultancy and recruitment support in Northern Ireland.

----------

Actual Experience PLC - Bath-headquartered analytics-as-a-service firm - Lands agreement with Verizon Communications Inc to supply its Human Experience Management service to increase employee productivity. Service can spot when digital applications are unresponsive and slow and can identify where improvements can be made.

----------

Solid State PLC - Worcestershire-based computing products manufacturer - Trading in first four months of financial year running to March 31, 2021 ahead of internal expectations. Revenue down 4% annually. Notes all manufacturing sites open again.

----------

Blue Star Capital PLC - esports and payments technology-focused investor - Investee Dynasty eSports Pte Ltd raises SGD3.1 million, about GBP1.7 million, to develop eSports Portal Management platform.

----------

Pires Investments PLC - London-based technology-focused investment firm - Investee Getvisibility signs public sector distribution deal with immixGroup, supplier of enterprise IT services to US public sector.

----------

Two Shields Investments PLC - investor in technology sector - BrandShield cyber protection investee sees new business in first half of 2020 alone equal all of 2019 as Covid-19 boosts demand. Has 11% stake in BrandShield. Also notes announcement by Power Metal Resources PLC - an exploration and development company - on Kalahari Key Mineral Exploration Ltd. KKME, targeting a nickel sulphide prospects in Botswana, is moving closer to drilling and is working with regulators to secure approval of an environmental plan. Power Metal holds just over an 18% stake in KKME, Two Shields holding is just shy of 18%.

----------

McKay Securities PLC - real estate investment trust focused on office, industrial and logistics properties - Acquires fully let logistics asset in Bracknell for GBP10.0 million, representing a net initial yield of 5.6%. Combined contracted rent at 1-4 Willoughby Road is GBP594,722 per year.

----------

Urban Logistics REIT PLC - real estate investment trust focused on industrial and logistics properties in UK - Acquires three assets in Colchester, Exeter and Nottingham for GBP36.8 million in total. Also enters into GBP151 million loan facility with Barclays, Santander and Lloyds to replace existing GBP76 million facility, which was due to expire in 2022. New facility has a three-year term with an option to extend by an extra two-years.

----------

Phoenix Spree Deutschland Ltd - investment company focused on Berlin residential real estate - Portfolio value at June 30 up 2.3% to EUR746.7 million from EUR730.2 million at end of December. Impact of Covid-19 on rent collection has been "limited". Says it is likely that Mietendeckel, a rent capping law in Berlin, will be successfully challenged.

----------

Gunsynd PLC - London-based investment firm - Notes investee Eagle Mountain Mining Ltd begins maiden drilling programme at 80%-owned Oracle Ridge copper mine near Tucson, Arizona.

----------

Cadence Minerals PLC - mineral resources investment company - Amapa iron ore project owner DEV Mineracao SA in constructive dialogue with creditors. Settlement with creditors remains the last precondition before Cadence takes 20% stake in project, located in Brazil.

----------

Westmount Energy Ltd - South America-focused energy investor - Notes Monday announcement by Ratio Petroleum Energy Ltd Partnership that Stena Carron drillship arrived at the Tanager-1 wellsite on the Kaieteur Block, offshore Guyana with drilling expected to kick off "imminently". Westmount holds roughly 0.7% stake in Ratio Petroleum and about 5.4% interest in Cataleya Energy Corp. Ratio and Cataleya hold 25% interest each in Kaieteur.

----------

Panther Metals PLC - Australia and Canada-focused minerals explorer - Finds a total of 253 geophysical anomalies from airborne survey of Big Bear gold project in Ontario, Canada. Notes 39 of 253 anomalies designated as "high-priority".

----------

Salt Lake Potash Ltd - Australia-focused miner - Set to raise AUD98.5 million, about GBP54.0 million, from combination of institutional share offer and retail entitlement offer. Raises AUD71 million from issue of 142.1 million shares as part of institutional offer, while AUD27 million retail entitlement offer is expected to close on August 25.

----------

Pure Gold Mining Inc - Canada-focused gold miner - Reports forest fire is currently active in town just south of Red Lake mine, Ontario. Pure Gold has temporarily suspended operations at mine.

----------

Great Western Mining Corp PLC - mineral explorer with projects in US state of Nevada - Produces first ever gold as a company. Although a small amount, Great Western hails the gold produced from RH Group area of its Mineral County area in Nevada as a "significant milestone".

----------

Shefa Gems Ltd - gemstone explorer in northern Israel - Receives ILS330,000, about GBP74,057, and 313,000 shares in major shareholder Shefa Yamim Ltd to settle debt. Shefa Gems has agreed not to sell Shefa Yamim shares in the market for a period of six months, which started July 20.

----------

Conroy Gold & Natural Resources PLC - gold explorer in Ireland and Finland - Raises GBP800,000 in placing and subscription of 3.2 million shares at 25 pence each. Including exercise of warrants announced in July, Conroy has secured over GBP1.0 million to bolster working capital.

----------

OptiBiotix Health PLC - York-based life sciences company - Results from peer-reviewed studies show its probiotic LPLDL reduces cholesterol and blood pressure. One study showed a 37% fall in total cholesterol and a 5.1% decline in blood pressure.

----------

RUA Life Sciences PLC - Ayrshire, Scotland-based medical device business - Hospital orders recovered from Covid-19 lows faster in US than Europe. US orders now at 90% of pre-pandemic levels, Europe at 67%. Notes furloughed staff have returned to work.

----------

Destiny Pharma PLC - clinical stage biotechnology firm - Safety review of phase 2b clinical trial of lead asset XF-73 completed by independent committee. Study can continue without any recommended changes and recruitment on track to be completed by end of 2020.

----------

Sareum Holdings PLC - drug developer focused on small molecule therapeutics to improve cancer and autoimmune treatment - Expects annual loss on ordinary activities to narrow to GBP960,000 from GBP1.5 million.

----------

Hemogenyx Pharmaceuticals PLC - pre-clinical stage biopharmaceutical firm headquartered in London - Enters into research pact with University of Pennsylvania to advance its chimeric antigen receptor T-cells towards clinical trial. CAR T-cells being developed for potential treatment of acute myeloid leukaemia.

----------

Fusion Antibodies PLC - pharmaceutical company based in Belfast - Notes partner Queens University Belfast awarded GBP50,000 in funding to develop new schemes to boost life science research in Northern Ireland.

----------

Cairn Homes PLC - Dublin-based housebuilder - Revenue in six months to June 30 down about 58% to roughly EUR80.6 million from EUR192.4 million a year earlier. New home sales down 47% to 207 from 390. Operating profit expected to fall 79% to about EUR5.6 million from EUR27.3 million.

----------

Modern Water PLC - London-based water supply company - Expects 2019 results to be released by end of month following audit delays.

----------

S & U PLC - Solihull-based lender focused on motor finance and property bridging - Sales at Advantage Finance recover to nearly 80% of normal levels as more car sales outlets reopen. Advantage sales were previously as low as 40% of normal levels. Loan applications at record high at Advantage but transaction levels 25% less than last year due to tightened underwriting. Aspen benefits from housing sector reopening with new transactions in July being above budget.

----------

Appreciate Group PLC - Liverpool-based multi-retailer - Completes sale of Budworth Properties Ltd unit which owns Valley Road, Birkenhead land and buildings for GBP3.2 million.

----------

Walker Greenbank PLC - Buckinghamshire-based interior furnishings firm - Total brand sales, before licensing, discounts and rebates, in six months to July 31 down 28% annually. In UK, its largest market, sales down 31%. In international arm, sales fell 24%. Notes early pain from Covid-19 but gained momentum as half ended.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
13 Jun 2019 15:49

Sareum Plans To Start Human Trials Of Two Drug Candidates In 2020

(Alliance News) - Sareum Holdings PLC on Thursday said it has been focusing on toxicology studies in its development of drug candidates SDC-1801 and SDC-1802 with a view to CONDUCT human trials in

Read more
3 Jun 2019 17:38

Sareum Notes Sierra Oncology's Positive Preliminary Results Of SRA737

LONDON (Alliance News) - Sareum Holdings PLC on Monday said it noted its licensee Sierra Oncology's webcast discussing clinical findings and possible next steps for SRA737, its oral checkpoint

Read more
3 Jun 2019 10:02

Sareum Reports Positive Data From Trials Of SRA737 In Advanced Cancer

LONDON (Alliance News) - Sareum Holdings PLC on Monday said that Sierra Oncology reported positive preliminary clinical data from two in-human studies of SRA737.Shares in the drug company a

Read more
4 Mar 2019 10:58

Sareum Interim Loss Deepens On Costs As Pipeline Continues Progress

LONDON (Alliance News) - Cancer drug discovery firm Sareum Holdings PLC said Monday its interim loss widened as costs rose, but it made progress with its key developmental programmes.For to

Read more
4 Mar 2019 08:26

Sareum's loss widens as development costs expand

(Sharecast News) - Sareum Holdings' shares dropped on Monday after the company reported a widened interim loss due to rising costs, though it stated progress had been made with key development programmes.

Read more
28 Feb 2019 14:33

Sareum flags potentially significant findings for SRA737

(Sharecast News) - Specialist small molecule drug development company Sareum Holdings announced on Thursday that Sierra Oncology, the licence holder advancing clinical cancer candidate SRA737, had reported that an abstract reporting preclinical data for SRA737 - its Chk1 inhibitor - plus low dose gemcitabine (LDG), in combination with immunotherapy, had been selected for a late-breaking oral presentation at the American Association of Cancer Research annual meeting.

Read more
11 Dec 2018 15:55

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 12 DecemberBlancco Technology GroupBellwayVolution Shopping REIT (re voluntary 13 Asian 14 to

Read more
30 Nov 2018 11:48

Sareum Reports Efficacy Data For Immunotherapy Combination With SRA737

LONDON (Alliance News) - Sareum Holdings PLC said Friday that Sierra Oncology Inc reported preclinical efficacy data for an immunotherapy combination with its SRA737 inhibitor in lung licences the

Read more
26 Oct 2018 09:20

Sareum Holdings Raises GBP850,000 Via Share Placing (ALLISS)

LONDON (Alliance News) - Sareum Holdings PLC said Friday it raised GBP850,000 via the issue of 130.8 million shares to fund the development of its lead cancer and autoimmune drugs.The drug

Read more
26 Oct 2018 08:38

Sareum raises £850,000 to fund cancer inhibitor

(Sharecast News) - Drug maker Sareum has raised £850,000 to progress the development programme of its cancer inhibitor TYK2/JAK1.

Read more
1 Oct 2018 11:30

Sareum Swings To Annual Loss After Prior Year Profit From Associates

LONDON (Alliance News) - Sareum Holdings PLC on Monday said it swung to an annual loss after reporting a substantial share of profit from associates the year before.Shares in Sareum were at

Read more
26 Sep 2018 15:20

Sareum Holdings selects cancer therapy development candidate

(Sharecast News) - Drug discovery and development company Sareum Holdings has made the formal selection of a development candidate from its TYK2 inhibitor programme to advance through preclinical development as a potential new targeted therapy for certain cancers, it announced on Wednesday.

Read more
26 Sep 2018 14:05

Sareum Selects Candidate To Develop Cancer Treatment

LONDON (Alliance News) - Sareum Holdings PLC said Wednesday that it has selected the SDC-1802 molecule from the TYK2 inhibitor programme for further development as potential treatment for certain

Read more
11 Sep 2018 13:28

Sareum Holdings Expects To Swing To GBP1.5 Million Annual Loss

LONDON (Alliance News) - Sareum Holdings PLC said Tuesday it expects to report a loss in its annual results as it progresses on its programmes in autoimmune diseases and cancer.The drug it

Read more
10 Sep 2018 11:52

Sareum Picks SDC-1801 For Development As Autoimmune Disease Treatment

LONDON (Alliance News) - Sareum Holdings PLC said Monday it will develop SDC-1801 as a possible treatment for autoimmune diseases.The molecule, SDC-1801, has been formally selected for is a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.